This technology relates to a composition for culturing brain immune cells comprising Matrigel and Annexin A1 (ANXA1), and a method for preparing the same.
Existing in vitro culture materials have made it difficult to reproduce normal brain immune responses and control the overexpression of brain immune cells.
This technology adds Annexin A1 to Matrigel to create a culture environment similar to the human brain, thereby enhancing the viability and stability of astrocytes and microglia and suppressing reactive overexpression.
N/A
